[Effective evaluation of liver transplantation for hepatocellular carcinoma].
OBJECTIVE
To evaluate the effect of liver transplantation for hepatocellular carcinoma and to explore the suitable indication for liver transplantation for advanced primary hepatocellular carcinoma.


METHODS
Clinical data were collected and studied with 43 patients with cirrhosis who had unresectable hepatocellular carcinoma and who underwent liver transplantation from August, 2000 to December, 2003. All the survived patients were followed up.


RESULTS
The longest following period was 45 months. 18 patients died by the end of the April, 2004. The 1-year survival rate was 85.5%, the 2-year survival rate 65.5%, the 3-year survival rate was 43.0%.


CONCLUSIONS
In our country, some advanced primary hepatocellular carcinoma without extrahepatic metastasis is still indicated for liver transplantation. Some patients could have the opportunity to survive relatively long time.
Song
Shi-Bing
SB
Department of General Surgery, The Third Hospital of Peking University, Beijing 100083, China.
Zhang
Tong-Lin
TL
Xiu
Dian-Rong
DR
Yuan
Jiong
J
Wang
De-Chen
DC
Jiang
Bin
B
Wang
Chang-Ming
CM
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D015996:Survival Rate